| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |